Cytoki Pharma ApS: Financial statements 2021
CVR: 40594132
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Cytoki Pharma ApS (CVR 40594132) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -31,975,161 and a net result of DKK -29,753,257 compared with DKK -6,793,432 the year before. Equity in the 2021 report amounted to DKK 106,806,036. The solvency ratio was 91.9%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -31,975,161
- Profit/Loss
- DKK -29,753,257
- Equity
- DKK 106,806,036
- Total Assets
- DKK 116,214,029
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -32 mio. | -29.8 mio. | 106.8 mio. | 3 |
| 2020 | - | -6 mio. | -6.8 mio. | -9.8 mio. | 1 |
Official annual report
Find more companies like Cytoki Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Cytoki Pharma ApS has published its annual report for 2020. Gross profit came to DKK -6,039,747, and the net result was DKK -6,793,432.
As of June 21, 2021, is registered as an owner of Cytoki Pharma ApS with an ownership share of 5%.
As of June 21, 2021, is registered as an owner of Cytoki Pharma ApS with an ownership share of 5%.
As of April 28, 2021, Christian Ellebæk Elling has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, Karen Ina Barbara Wagner has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, Amanda Viven Gett-Chaperot has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, Daniel Bach Gonzalez has joined the board of directors of Cytoki Pharma ApS.
As of April 28, 2021, LUNDBECKFOND INVEST A/S is registered as an owner of Cytoki Pharma ApS with an ownership share of 25%.
About Cytoki Pharma ApS
Cytoki Pharma ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2019. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CytoKi Pharma ApS. The management consists of Anders Hagstrøm. The company's owners include LUNDBECKFOND INVEST A/S, 15-Bio ApS and YSIOS Biofund III, F.C.R.E. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -42,198,706 and a net result of DKK -43,800,007 compared with DKK -39,261,697 the year before. Equity in the 2025 report amounted to DKK 13,473,548.